N. Juhan

Replacement of the Replication Factors of Porcine Circovirus (PCV) Type 2 with Those of PCV Type 1 Greatly Enhances Viral Replication InVitro

N. M. Beach, X. Meng, L. Córdoba, 2010, Journal of Virology.

A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo.

X. Meng, J. Dicristina, S. Ramamoorthy, 2008, Vaccine.

Difference in severity of porcine circovirus type two-induced pathological lesions between Landrace and Pietrain pigs.

T. Opriessnig, P. Halbur, J. Lunney, 2009, Journal of animal science.

Molecular mechanisms of porcine circovirus 2 replication and pathogenesis

N. Juhan, 2007 .

Planned exposure to porcine circovirus type 2 by serum injection is not effective at preventing porcine circovirus associated disease

T. Opriessnig, P. Halbur, X. Meng, 2007 .

Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs

T. Opriessnig, P. Halbur, J. Prickett, 2010, Veterinary research.

The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant.

T. Opriessnig, T. LeRoith, X. Meng, 2010, Virus research.

Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions.

Douglas E. Jones, T. Opriessnig, P. Halbur, 2009, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.